| Pharmaceutical Information |
| Drug Name |
Pyrazinamide |
| Drug ID |
BADD_D01880 |
| Description |
A pyrazine that is used therapeutically as an antitubercular agent. |
| Indications and Usage |
For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. |
| Marketing Status |
Prescription |
| ATC Code |
J04AK01 |
| DrugBank ID |
DB00339
|
| KEGG ID |
D00144
|
| MeSH ID |
D011718
|
| PubChem ID |
1046
|
| TTD Drug ID |
D0XF8W
|
| NDC Product Code |
70518-2534; 66639-165; 70954-484; 61748-012; 33342-447; 50090-0520; 0904-6696; 11712-815; 49452-6135; 50090-0521; 71052-311 |
| Synonyms |
Pyrazinamide | Tisamid |
|
| Chemical Information |
| Molecular Formula |
C5H5N3O |
| CAS Registry Number |
98-96-4 |
| SMILES |
C1=CN=C(C=N1)C(=O)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
